Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pantherics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Pantherics

Pantherics

Pantherics: Innovating therapy through peripheral GABAA receptor modulation.

HQ
Milwaukee, WI, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Pantherics was founded with the core mission of innovating therapeutic solutions through the modulation of peripheral GABAA receptors. The company's vision is to revolutionize the treatment of respiratory conditions, particularly asthma, by developing novel therapies that offer better control and fewer side effects compared to existing treatments. Pantherics' primary product is an oral new chemical entity (NCE) designed to target peripheral GABAA receptors, aiming to provide a groundbreaking approach to asthma management.

Notable affiliated individuals and investors include leading experts in pharmacology and respiratory medicine, though specific names are not disclosed. Pantherics has achieved significant milestones in preclinical development, demonstrating the potential efficacy and safety of their lead compound. The overall impact of Pantherics' work could be substantial, offering a new therapeutic avenue for millions of asthma patients who struggle with uncontrolled symptoms and frequent hospitalizations.

Pantherics - Similar Companies

Areteia Therapeutics logo

Areteia Therapeutics

areteiatx.com

Respira Therapeutics logo

Respira Therapeutics

Aero Therapeutics logo

Aero Therapeutics

Health Care Originals logo

Health Care Originals

PanTheryx logo

PanTheryx

pantheryx.com

Pneuma Respiratory logo

Pneuma Respiratory

Peroxitech Therapeutics logo

Peroxitech Therapeutics

Epalex logo

Epalex

epalex.com

Respirics logo

Respirics

Aer Therapeutics logo

Aer Therapeutics

Function Therapeutics logo

Function Therapeutics

functiontx.com

Path BioAnalytics logo

Path BioAnalytics

Precision Theranostics logo

Precision Theranostics

Pulmatrix logo

Pulmatrix

pulmatrix.com

VitalFlo logo

VitalFlo

vitalflohealth.com

Pantherics - Quick Facts

Who are Pantherics' competitors?

Companies similar to Pantherics include Areteia Therapeutics, Respira Therapeutics, Aero Therapeutics and Health Care Originals.

When was Pantherics founded?

Pantherics was founded in 2019.

Where is Pantherics' headquarters located?

Pantherics' headquarters is located in Milwaukee, WI, US.

When was Pantherics' last funding round?

Pantherics' most recent funding round was for $255.8k (USD) in August 2022.

How much has Pantherics raised to-date?

As of Aug 11, 2022, Pantherics has raised a total of $518.6k (USD).

How many employees does Pantherics have?

Pantherics has 5 employees as of Feb 4, 2024.

Pantherics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Asthma Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified